Aivre's new AI-driven platform is the first in the U.S. to complete UAD 3.6 verification, promising faster, more accurate ...

Aivre in Detroit has launched an AI-powered appraisal platform, which it states is the first in the United States to complete the Uniform Appraisal Dataset (UAD) 3.6 verification process with […] ...

Aivre Launches Industry’s First AI-Powered Platform Verified to Support New Uniform Appraisal Dataset 3.6 Standards Aivre ...

NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”. The ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. Based in Pittsburgh, Pennsylvania, PNC Bank is one of the largest banks in the U.S. It has ...

Suggested remit: To appraise the clinical and cost effectiveness of delgocitinib within its marketing authorisation for treating moderate to severe chronic hand eczema.